semaglutide oral approval Novo Nordisk's Wegovy® pill (oral 25 mg, once daily) has just been approved by the US FDA as the first GLP‑1 receptor agonist for long‑term weight management and CV risk Oral GLP-1 Wegovy chases approval

Modulation of inflammation and immunity by dietary conjugated linoleic acid

Both better insulin sensitivity and weight loss are linked to lower uric acid levels

Nc Gim Lu Hu C Daesang Hn Quc l nc p c ln men t qu

53 Muscle-specific VEGF deletion induces muscle capillary rarefaction and insulin resistance 54,55 and, in the insulin resistant state, VEGF action on muscle vasculature is impaired, which triggers muscle capillary regression

Microcrystalline Cellulose: An inert, non-allergenic stabilizer that supports consistent release of the active ingredient

Figure 2 The potential signal is the arachidonic acid (AA) oxidation product released by ferroptosis cells therefore, it has been hypothesized that lipoxygenases (LOXs) can not only induce the PUFAs production but also promote ferroptosis cells to release immune signals and regulate tumor immunity (77)